Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyJournal of clinical oncology, 2021-07, Vol.39 (20), p.JCO2003488-2303 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03488 ;PMID: 33914595Full text available |
|
2 |
Material Type: Article
|
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 studyThe lancet oncology, 2021-11, Vol.22 (11), p.1541-1559 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00402-2 ;PMID: 34600602Full text available |
|
3 |
Material Type: Article
|
Use of Prednisone With Abiraterone Acetate in Metastatic Castration‐Resistant Prostate CancerThe oncologist (Dayton, Ohio), 2014-12, Vol.19 (12), p.1231-1240 [Peer Reviewed Journal]2014 AlphaMed Press ;AlphaMed Press. ;AlphaMed Press 2014 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2014-0167 ;PMID: 25361624Full text available |
|
4 |
Material Type: Article
|
Population-based study of disease trajectory after radical treatment for high-risk prostate cancerBJU international, 2024-04 [Peer Reviewed Journal]2024 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International. ;ISSN: 1464-4096 ;ISSN: 1464-410X ;EISSN: 1464-410X ;DOI: 10.1111/bju.16362 ;PMID: 38621388Full text available |
|
5 |
Material Type: Article
|
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patientsWorld journal of urology, 2023-12, Vol.41 (12), p.3535-3542 [Peer Reviewed Journal]The Author(s) 2023 ;EISSN: 1433-8726 ;DOI: 10.1007/s00345-023-04680-wDigital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer : A subgroup analysis of the randomised clinical TITAN studyEuropean journal of cancer (1990), 2023-11, Vol.193 [Peer Reviewed Journal]ISSN: 0959-8049 ;EISSN: 1879-0852 ;DOI: 10.1016/j.ejca.2023.113290Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTANBritish journal of cancer, 2024-01, Vol.130 (1), p.73-81 [Peer Reviewed Journal]2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02492-8 ;PMID: 37951974Full text available |
|
8 |
Material Type: Article
|
Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamideProstate cancer and prostatic diseases, 2023-03, Vol.26 (1), p.156-161 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2022. corrected publication 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 1365-7852 ;EISSN: 1476-5608 ;DOI: 10.1038/s41391-022-00592-9 ;PMID: 36209239Full text available |
|
9 |
Material Type: Article
|
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN studyFuture oncology (London, England), 2024-03, Vol.20 (10), p.563-578 [Peer Reviewed Journal]2023 The Authors ;ISSN: 1479-6694 ;EISSN: 1744-8301 ;DOI: 10.2217/fon-2023-0649Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Increased levels and activity of E2F1 transcription factor in myelodysplastic bone marrowInternational journal of hematology, 2004-08, Vol.80 (2), p.146-154 [Peer Reviewed Journal]2004 INIST-CNRS ;The Japanese Society of Hematology 2004 ;ISSN: 0925-5710 ;EISSN: 1865-3774 ;DOI: 10.1532/IJH97.NA0303 ;PMID: 15481443Full text available |
|
11 |
Material Type: Article
|
Erythropoiesis-stimulating agents versus RBC transfusion in MDS: comparison of long-term outcomesFuture oncology (London, England), 2007-08, Vol.3 (4), p.397-403 [Peer Reviewed Journal]2007 © Future Medicine Ltd ;ISSN: 1479-6694 ;EISSN: 1744-8301 ;DOI: 10.2217/14796694.3.4.397 ;PMID: 17661714Full text available |
|
12 |
Material Type: Article
|
Clinical implications of advanced molecular cytogenetics in cancerExpert review of molecular diagnostics, 2004-01, Vol.4 (1), p.71-81 [Peer Reviewed Journal]2004 Future Drugs Ltd. All rights reserved. 2004 ;Copyright Future Drugs Ltd. ;ISSN: 1473-7159 ;EISSN: 1744-8352 ;DOI: 10.1586/14737159.4.1.71 ;PMID: 14711351Full text available |
|
13 |
Material Type: Article
|
Correlation of tumor necrosis factor α (TNFα) with high Caspase 3-like activity in myelodysplastic syndromesCancer letters, 1999-06, Vol.140 (1), p.201-207 [Peer Reviewed Journal]1999 ;1999 INIST-CNRS ;ISSN: 0304-3835 ;EISSN: 1872-7980 ;DOI: 10.1016/S0304-3835(99)00072-5 ;PMID: 10403560 ;CODEN: CALEDQFull text available |
|
14 |
Material Type: Article
|
PATIENT RETENTION AND PHYSICIAN ENGAGEMENT STRATEGIES DURING THE COVID-19 PANDEMIC IN THE PHASE 3 ATLAS STUDY OF APALUTAMIDE ADDED TO ANDROGEN DEPRIVATION THERAPY IN HIGHRISK LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCEROncology nursing forum, 2023-03, Vol.50 (2), p.A13-A14 [Peer Reviewed Journal]Copyright Oncology Nursing Society Mar 2023 ;ISSN: 0190-535X ;EISSN: 1538-0688Full text available |
|
15 |
Material Type: Article
|
DEVELOPMENT OF A RETROSPECTIVE CLINICIAN-ADMINISTERED SURVEY STUDY (RETROCLASS) ASSESSING EFFICACY AND TREATMENT BURDEN IN PROSTATE CANCER PATIENTSOncology nursing forum, 2022-03, Vol.49 (2), p.24-25 [Peer Reviewed Journal]Copyright Oncology Nursing Society Mar 2022 ;ISSN: 0190-535X ;EISSN: 1538-0688Full text available |
|
16 |
Material Type: Article
|
Apalutamide plus abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, phase 3 studyThe lancet oncology, 2021-09, Vol.22 (11), p.1541-1559 [Peer Reviewed Journal]ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00402-2 ;PMID: 34600602Full text available |
|
17 |
Material Type: Article
|
Caspases and apoptosis in myelodysplastic syndromesExperimental hematology, 2000-12, Vol.28 (12), p.1310-1311 [Peer Reviewed Journal]2000 International Society for Experimental Hematology. ;ISSN: 0301-472X ;EISSN: 1873-2399 ;DOI: 10.1016/S0301-472X(00)00607-X ;PMID: 11188920Full text available |
|
18 |
Material Type: Article
|
In ReplyThe oncologist (Dayton, Ohio), 2015-05, Vol.20 (5), p.e14-e14 [Peer Reviewed Journal]AlphaMed Press 2015 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0010 ;PMID: 25888269Full text available |
|
19 |
Material Type: Article
|
In ReplyThe oncologist (Dayton, Ohio), 2015-05, Vol.20 (5), p.e14-e14 [Peer Reviewed Journal]2015 AlphaMed Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0010Full text available |
|
20 |
Material Type: Article
|
In ReplyThe oncologist (Dayton, Ohio), 2015-05, Vol.20 (5), p.e14-e14 [Peer Reviewed Journal]ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2015-0010Full text available |